INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 48m ago
HOUSE PTR8m ago
SEC 13F8m ago
ROBINHOOD CHAIN8m ago
Public company

SGPSpyGlass Pharma, Inc.

CIK 0001778922

EDGAR filingsOpen in network
Disclosed transactions8
Buys / sells2 / 0
Max Insider Score50
Connections7with evidence

SGP · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
47
KA
Khan Bilal ArshadDirector
SGPSpyGlass Pharma, Inc.
Open-market purchase
BUY$320K
20.0K sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 3841 · Surgical & Medical Instruments & Apparatus · Nov 5, 2026
  • ← Insider ofevidence
    Dennewill James Robert Jr.Chief Operating Officer · Feb 9, 2026
  • ← Insider ofevidence
    Mooney Patrick H.Director, Chief Executive Officer · Feb 9, 2026
  • ← Insider ofevidence
    Pujara Chetan PratapChief R&D Officer · Feb 9, 2026
50
KA
Khan Bilal ArshadDirector
SGPSpyGlass Pharma, Inc.
Open-market purchase
BUY
$1.84M
115.0K sh
Feb 9, 2026
Feb 11, 2026
traded Feb 9, 2026
+2d
SEC FORM 4

Evidence

9
PP
Pujara Chetan PratapChief R&D Officer
SGPSpyGlass Pharma, Inc.
Grant or award
A—
105.0K sh
Feb 5, 2026Feb 9, 2026
traded Feb 5, 2026
+4dSEC FORM 4

Evidence

9
DR
Dennewill James Robert Jr.Chief Operating Officer
SGPSpyGlass Pharma, Inc.
Grant or award
A—
105.0K sh
Feb 5, 2026Feb 9, 2026
traded Feb 5, 2026
+4dSEC FORM 4

Evidence

9
SZ
Scheiner ZacharyDirector
SGPSpyGlass Pharma, Inc.
Grant or award
A—
27.4K sh
Feb 5, 2026Feb 9, 2026
traded Feb 5, 2026
+4dSEC FORM 4

Evidence

9
MH
Mooney Patrick H.Director, Chief Executive Officer
SGPSpyGlass Pharma, Inc.
Grant or award
A—
300.0K sh
Feb 5, 2026Feb 9, 2026
traded Feb 5, 2026
+4dSEC FORM 4

Evidence

9
KY
Kahook Malik Y.Director, See remarks
SGPSpyGlass Pharma, Inc.
Grant or award
A—
105.0K sh
Feb 5, 2026Feb 9, 2026
traded Feb 5, 2026
+4dSEC FORM 4

Evidence

9
KA
Khan Bilal ArshadDirector
SGPSpyGlass Pharma, Inc.
Grant or award
A—
13.7K sh
Feb 5, 2026Feb 9, 2026
traded Feb 5, 2026
+4dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Scheiner ZacharyDirector · Feb 9, 2026
  • ← Insider ofevidence
    Khan Bilal ArshadDirector · Feb 9, 2026
  • ← Insider ofevidence
    Kahook Malik Y.Director, See remarks · Feb 9, 2026